Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shilpi Wadhwa is active.

Publication


Featured researches published by Shilpi Wadhwa.


Archive | 2013

Colon and Rectum Carcinoma

David Y. Johnson; Shilpi Wadhwa; Frank E. Johnson

The International Agency for Research on Cancer (IARC), a component of the World Health Organization (WHO), estimated that there were 1,023,152 new cases of colorectal cancers worldwide in 2002 [1]. The IARC also estimated that there were 528,978 deaths due to this cause in 2002 [1].


Archive | 2013

Vaginal and Vulvar Carcinoma

David Y. Johnson; Shilpi Wadhwa; Frank E. Johnson

The data for the estimated new cases and deaths worldwide in 2002 for vaginal and vulvar carcinoma were not available through International Agency for Research on Cancer (IARC), a component of the World Health Organization (WHO) [1].


Archive | 2013

Liver and Biliary Tract Carcinoma

David Y. Johnson; Shilpi Wadhwa; Frank E. Johnson

The International Agency for Research on Cancer (IARC), a component of the World Health Organization (WHO), estimated that there were 626,162 new cases of liver carcinoma worldwide in 2002 [1]. The IARC also estimated that there were 598,321 deaths due to this cause in 2002 [1].


Archive | 2013

Upper Aerodigestive Tract Carcinoma

David Y. Johnson; Shilpi Wadhwa; Frank E. Johnson

The International Agency for Research on Cancer (IARC), a component of the World Health Organization (WHO), estimated that there were 484,628 new cases of upper aerodigestive tract carcinoma worldwide in 2002 [1]. The IARC also estimated that there were 261,784 deaths due to this cause in 2002 [1].


Archive | 2013

Urinary Bladder Carcinoma

David Y. Johnson; Shilpi Wadhwa; Frank E. Johnson

The International Agency for Research on Cancer (IARC), a component of the World Health Organization (WHO), estimated that there were 356,557 new cases of bladder carcinoma worldwide in 2002 [1]. The IARC also estimated that there were 145,009 deaths due to this cause in 2002 [1].


Archive | 2013

Glioma of the Central Nervous System

David Y. Johnson; Shilpi Wadhwa; Frank E. Johnson

The International Agency for Research on Cancer (IARC), a component of the World Health Organization (WHO), estimated that there were 189,485 new cases of CNS glioma (specified as cancer of the brain and other nervous system) worldwide in 2002 [1]. The IARC also estimated that there were 141,650 deaths due to this cause in 2002 [1].


Archive | 2013

Thyroid (Papillary, Follicular, Medullary, Hürthle Cell) Carcinoma

David Y. Johnson; Shilpi Wadhwa; Frank E. Johnson

The International Agency for Research on Cancer (IARC), a component of the World Health Organization (WHO), estimated that there were 141,013 new cases of thyroid (papillary, follicular, Hurthle cell) carcinoma worldwide in 2002 [1]. The IARC estimated that there were 35,375 deaths due to this cause in 2002 [1].


Archive | 2013

Soft Tissue Sarcoma

David Y. Johnson; Shilpi Wadhwa; Frank E. Johnson

Data concerning the estimated new cases and deaths worldwide in 2002 for soft tissue sarcoma were not available through the International Agency for Research on Cancer (IARC), a component of the World Health Organization (WHO) [1].


Archive | 2013

Osteogenic Sarcoma and Dedifferentiated Chondrosarcoma

David Y. Johnson; Shilpi Wadhwa; Frank E. Johnson

Data concerning estimated new cases and deaths worldwide in 2002 for osteogenic sarcoma and dedifferentiated chondrosarcoma were not available through the International Agency for Research on Cancer (IARC), a component of the World Health Organization (WHO) [1].


Archive | 2013

Lymphoma (Following Autologous Stem Cell Transplant)

Shilpi Wadhwa; David Y. Johnson; Frank E. Johnson

Although treatment strategies for lymphoma may include hematopoietic cell transplant, quantitative surveillance recommendations that were accessed for lymphoma patients did not distinguish between those with or without transplant. The guidelines in Chapter 26 should be considered applicable to all lymphoma patients, including those whose treatment includes transplant. The surveillance strategies related to immunosuppression are not discussed in this textbook.

Collaboration


Dive into the Shilpi Wadhwa's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge